日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ACTR-21. MANAGEMENT OF OCULAR SIDE EFFECTS IN PATIENTS WITH EGFR-AMPLIFIED GLIOBLASTOMA RECEIVING DEPATUXIZUMAB MAFODOTIN

ACTR-21. 接受德帕妥珠单抗治疗的EGFR扩增型胶质母细胞瘤患者的眼部副作用管理

Wodzinski, M A; Lawrence, A C; Nikolovska-Kotevska, Mimoza; Karadzova-Stojanoska, Anzelika; Pavlova, Sonja; Vidinikj, Sonja; Sandevska, Emilija; Bojadzioska, Maja; Gucev, Filip; Petrova, Sanja; Vasilevska, Ana; Vejseli, Ron; Jara, Maria Daniela Jarrin; Kladias, Michael; Coyle, Christina; McCarthy, Aonghus; McKenna, Susan; Hall, Keira; Niland, Aileen; Boran, Gerard P; Moran, Carla M; Kim, Stella; Moazami, Golnaz; Gomez, Erica; Ocampo, Christopher; Bain, Earle; Guseva, Maria; Macsai, Marian